Daniel Oliver

1.3k total citations
50 papers, 887 citations indexed

About

Daniel Oliver is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel Oliver has authored 50 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel Oliver's work include Brain Metastases and Treatment (28 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Treatments and Mutations (12 papers). Daniel Oliver is often cited by papers focused on Brain Metastases and Treatment (28 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Treatments and Mutations (12 papers). Daniel Oliver collaborates with scholars based in United States, Australia and Switzerland. Daniel Oliver's co-authors include Mohammad K. Khan, Kirtesh R. Patel, Kamran A. Ahmed, David H. Lawson, G.Q. Yang, Monica Rizzo, Mudit Chowdhary, Faisal Khosa, Yuan Liu and Sana Shoukat and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Daniel Oliver

47 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Oliver United States 14 523 511 201 118 118 50 887
Nicholas Figura United States 14 430 0.8× 470 0.9× 149 0.7× 61 0.5× 94 0.8× 52 717
Suriya Jeyapalan United States 13 263 0.5× 262 0.5× 372 1.9× 109 0.9× 65 0.6× 33 926
Jim Zhong United States 17 451 0.9× 294 0.6× 331 1.6× 136 1.2× 81 0.7× 55 852
René-Olivier Mirimanoff Switzerland 10 327 0.6× 311 0.6× 394 2.0× 124 1.1× 90 0.8× 15 899
Rikiya Nakamura Japan 19 360 0.7× 622 1.2× 112 0.6× 150 1.3× 265 2.2× 61 984
C.J.A. Punt Netherlands 11 216 0.4× 299 0.6× 161 0.8× 72 0.6× 75 0.6× 26 624
Binglin Yue United States 16 335 0.6× 320 0.6× 75 0.4× 110 0.9× 139 1.2× 41 857
Pierpaolo Pastina Italy 17 211 0.4× 319 0.6× 90 0.4× 165 1.4× 75 0.6× 39 599
Bernies van der Hiel Netherlands 18 149 0.3× 386 0.8× 107 0.5× 214 1.8× 101 0.9× 55 922
Xianxin Qiu China 16 242 0.5× 190 0.4× 155 0.8× 108 0.9× 240 2.0× 46 790

Countries citing papers authored by Daniel Oliver

Since Specialization
Citations

This map shows the geographic impact of Daniel Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Oliver more than expected).

Fields of papers citing papers by Daniel Oliver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Oliver. The network helps show where Daniel Oliver may publish in the future.

Co-authorship network of co-authors of Daniel Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Oliver. A scholar is included among the top collaborators of Daniel Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Oliver. Daniel Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perez, Bradford A., José Peñagarícano, Jimmy J. Caudell, et al.. (2024). Technical feasibility of novel immunostimulatory low‐dose radiation for polymetastatic disease with CBCT‐based online adaptive and conventional approaches. Journal of Applied Clinical Medical Physics. 25(6). e14303–e14303. 2 indexed citations
2.
Udovicich, Cristian, Kendrick Koo, John Michael Bryant, et al.. (2024). International collaboration of neoadjuvant stereotactic radiosurgery for brain metastases: The INTERNEO individual patient data pooled analysis. Radiotherapy and Oncology. 202. 110641–110641. 2 indexed citations
3.
Mills, Matthew N., Nikhil I. Khushalani, Peter Forsyth, et al.. (2024). Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery. Journal of Neuro-Oncology. 166(3). 431–440. 4 indexed citations
4.
Ahmed, Kamran A., Youngchul Kim, Daniel Oliver, et al.. (2024). Phase I/II study of stereotactic radiation and sacituzumab govitecan with zimberelimab in the management of metastatic triple negative breast cancer with brain metastases.. Journal of Clinical Oncology. 42(16_suppl). TPS1140–TPS1140.
5.
6.
Bryant, John Michael, Joseph Weygand, Jacqueline M. Andreozzi, et al.. (2023). Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions. Cancers. 15(21). 5200–5200. 5 indexed citations
7.
Mills, Matthew N., Yuki Kawahara, Nicholas Figura, et al.. (2021). The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs. Breast Cancer Research and Treatment. 191(1). 209–217. 8 indexed citations
8.
Mills, Matthew N., Nicholas Figura, Daniel Oliver, et al.. (2021). Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases. Journal of Neuro-Oncology. 152(3). 591–601. 8 indexed citations
9.
Scott, Jacob G., Patrick Ellsworth, Jessica Scarborough, et al.. (2021). Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis. The Lancet Oncology. 22(9). 1221–1229. 90 indexed citations
10.
Yang, G.Q., Matthew N. Mills, Youngchul Kim, et al.. (2020). Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation. Blood Cancer Journal. 9(12). 104–104. 11 indexed citations
11.
Figura, Nicholas, Daniel Oliver, Homan Mohammadi, et al.. (2019). Novel Dose Escalation Approaches for Stereotactic Body Radiotherapy to Adrenal Oligometastases. American Journal of Clinical Oncology. 43(2). 107–114. 12 indexed citations
12.
Oliver, Daniel, Homan Mohammadi, Nicholas Figura, et al.. (2019). Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy. Seminars in Radiation Oncology. 29(2). 111–125. 3 indexed citations
13.
Perez, Matthew, Amanda Holstein, Daniel Oliver, et al.. (2018). Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?. Annals of Surgical Oncology. 25(11). 3334–3340. 37 indexed citations
14.
Oliver, Daniel, G. Daniel Grass, A.O. Naghavi, et al.. (2018). Extracranial metastatic burden in extensive-stage small cell lung cancer: implications for prophylactic cranial irradiation. Journal of Thoracic Disease. 10(7). 4321–4327. 5 indexed citations
15.
Mills, Matthew N., G.Q. Yang, Daniel Oliver, et al.. (2018). Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis. European Journal of Cancer. 98. 48–58. 62 indexed citations
16.
Armanious, Merna, et al.. (2018). Cardiovascular effects of radiation therapy. Current Problems in Cancer. 42(4). 433–442. 42 indexed citations
17.
Yuan, Zhigang, Kamran A. Ahmed, G. Daniel Grass, et al.. (2017). Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung. Journal of Thoracic Oncology. 12(9). e135–e136. 42 indexed citations
18.
Ström, T., Javier F. Torres–Roca, Akash D. Parekh, et al.. (2017). Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma. Journal of the National Comprehensive Cancer Network. 15(4). 473–482. 24 indexed citations
19.
Oliver, Daniel, Kirtesh R. Patel, Jeffrey M. Switchenko, et al.. (2015). Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Research. 26(1). 35–41. 18 indexed citations
20.
Oliver, Daniel, Kirtesh R. Patel, Douglas Parker, et al.. (2015). The emerging role of radiotherapy for desmoplastic melanoma and implications for future research. Melanoma Research. 25(2). 95–102. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026